Approved Drugs May Reduce Anthracycline Drug–Related Cardiotoxicity

Article navigation

Research Watch| November 01 2021

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2021

American Association for Cancer Research.

Cancer Discov (2021) 11 (11): 2669.

Abstract

In a phase III trial, ramipril, bisoprolol, or the combination diminished subclinical cardiotoxicity.

2021

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.